Dariohealth Corp. · NASDAQ:DRIO
Dariohealth — Q2 2026 Earnings Presentation
33 slides from Dariohealth's earnings presentation, Aug 11, 2026
Slide 1: AI-Proprietary Data Driven Platform For Health
DarioHealth Corp. AI-Proprietary Data Driven Platform For Health July 2026
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation of DarioHealth Corp. (“Dario”, the “Company”, “we” and “our”) and statements of our management or agents related thereto contain or may contain forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act
Slide 3: Our Purpose
Our Purpose Leveraging 13B+ proprietary data points and AI to create a future where healthy change is effortless and accessible to all. Dario is the only health-tech company delivering end-to-end multi-condition chronic care solutions from digital engagement to clinical intervention. DRIO | Nasdaq l
Slide 4: A Snapshot of the DarioHealth Opportunity
A Snapshot of the DarioHealth Opportunity AI-Powered Proprietary Data Advantage ▪ Leveraging 13B+ user data points to improve and build out clinical services and support user navigation 13B+ 10-15% ▪ Comprehensive AI implementation across operations driving significant cost reductions and workflow o
Slide 5: One Multi-Condition Platform. Powerful Engagement. Proven Outcomes.
One Multi-Condition Platform. Powerful Engagement. Proven Outcomes. One Integrated, Gen-AI-Powered, Human-Enabled, A Wealth of Benefits that Engage Members, Drive Digital Engagement Platform Real Behavioral Change, and Deliver Timely Clinical Interventions Cardiometabolic Health Diabetes Pre-Diabete
Slide 6: Delivering Measurable Clinical Outcomes and ROI
Delivering Measurable Clinical Outcomes and ROI Real-world, third-party-validated clinical studies have proven product excellence and helped quantify the benefits for clients and members CLINICAL OUTCOMES ROI USER EXPERIENCE Diabetes & Hypertension 13 mmHg Reduction $5,077 App Store Rating in systol
Slide 7: Powerful Market Tailwinds Driving Digital Chronic Care Adoption
Powerful Market Tailwinds Driving Digital Chronic Care Adoption Converging cost pressures, treatment innovations, and AI capabilities are driving a rapid shift to integrated digital solutions 90% 3 in 4 Multi-Condition Care Cost Pressures Drive of aggregate U.S. healthcare adults in the U.S. Gap Dig
Slide 8: Dario's Multi-Condition Digital Platform Addresses $250 Billion Market
Dario’s Multi-Condition Digital Platform Addresses $250 Billion Market of U.S. adults live with two 75% Adults in the U.S. have a chronic disease >50% or more comorbid conditions $1 Trillion+ TAM >$250 Billion SAM Diabetes Behavioral Health 38M 61M $307B $102B Diabetes Behavioral Health Hypertension
Slide 9: Building the Multi-Condition Platform: 10 Years of Strategic Growth
Building the Multi-Condition Platform: 10 Years of Strategic Growth Dario's early leadership in building a comprehensive, multi-condition platform demonstrates strategic vision realized through disciplined execution ahead of market demand plus + Dario’s Platform Addresses 6+ Conditions Women’s Mid-L
Slide 10: DarioHealth Has Driven the Industry Shift to Multi-Condition Platforms
DarioHealth Has Driven the Industry Shift to Multi-Condition Platforms As an early pioneer of the multi-condition strategy, Dario has transformed customer expectations and buyer preferences – driving industry-wide movement away from costly, fragmented point solutions towards integrated platforms tha
Slide 11: Today Dario is Leading the Next Big Shift in Healthcare
Today Dario is Leading the Next Big Shift in Healthcare A category expansion from digital engagement to clinical intervention. Dario recently announced an expansion into provider-backed care that substantially expands its addressable markets Before Dario Now Provider-backed care National Clinical In
Slide 12: Dario's Trailblazing Stands Apart
Dario’s Trailblazing Stands Apart Most competitors excel at one part of the care journey. Dario is integrating the entire journey. AI & Data Engagement Risk Detection Provider Care Longitudinal NEW Capability Other Digital Health Solutions Dario Address multi-vendor responsibilities No Multi-conditi
Slide 13: Addressing Healthcare's Most Costly and Prevalent Conditions
Addressing Healthcare’s Most Costly and Prevalent Conditions Dario’s platform targets chronic conditions driving the highest healthcare costs and member prevalence Pre/Diabetes Diabetes Hypertension Weight Posture Mental CARDIOMETABOLIC ADD ONS Management Management Health with GLP-1 Support Dario S
Slide 14: Comprehensive Multi-Model Support to Drive Sustained Engagement
Comprehensive Multi-Model Support to Drive Sustained Engagement Dario's digital-first, human-centered approach combines connected devices, AI-powered coaching, community support, and clinical services to deliver personalized care pathways that maximize member outcomes and ROI MODES OF ENGAGEMENT Beh
Slide 15: The Stack Unique to Dario
The Stack Unique to Dario DATA & AI ADVANTAGE Fully Vertically Integrated, from FDA-cleared hardware to proprietary data to Gen AI. We own every layer. 1 2 3 4 FDA-Cleared 13B+ Real-World DarioIQ Member Connected Devices Data Points AI Engine Engagement Layer Proprietary hardware Tied to actual clin
Slide 16: The Largest Database of its Kind
The Largest Database of its Kind DATA & AI ADVANTAGE Every member added deepens the moat. The dataset that built the advantage is the same one that compounds it. Member joins, device activates Payers see ROI, Real-time clinical platform expands data captured 13B+ Data Points New AI models & Growing
Slide 17: DarioIQ - Dario's Proprietary Gen-AI layer is active today
DATA & AI ADVANTAGE DarioIQ - Dario’s Proprietary Gen-AI layer is active today Engine driving engagement and value across the business now What DarioIQ Is Doing Now What It’s Producing Personalizes at the member level, not the segment Behavior-triggered engagement, now scaling to a broader member po
Slide 18: Why General AI Models Can't Catch Up
Why General AI Models Can’t Catch Up DATA & AI ADVANTAGE Every advance in AI raises the value of the underlying data. We own that data. General AI / LLMs DarioIQ on the Dario Platform ✕ Trained on public internet data ✓ Trained on 13B+ real clinical outcomes ✕ No longitudinal individual data ✓ Years
Slide 19: AI also Across Dario Operations
AI also Across Dario Operations DATA & AI ADVANTAGE Active across the company today — automating workflows and compressing cost and cycle time. Workflow Automation Automating work across product, data, clinical ops, support, and finance AI inside the operating model R&D Acceleration AI across backlo
Slide 20: Commercial Overview
Commercial Overview DRIO | Nasdaq listed | 20
Slide 21: How Dario Works for Its Customers and Members
How Dario Works for Its Customers and Members Enrolling & Engaging Members Total Eligible Drive Create Power Improve User Population Enrollment Engagement Personalization Outcomes 40% 35% 75% 2.4 2-5X ROI Eligible population Average member Average member Average number 100+ studies across 6+ conditi
Slide 22: Dario's Competitive Advantage: Multiple Conditions, Better Outcomes, Higher Value
Dario’s Competitive Advantage: Multiple Conditions, Better Outcomes, Higher Value Among the few consumer-centric, multi-condition solutions with real world clinical studies that show tangible results for payers, employers and end users alike Comprehensive user-centric experience 6 drives higher clie
Slide 23: Growing Blue-Chip Client Base and Channel Partners
Growing Blue-Chip Client Base and Channel Partners Clients Partners B2B2C Employer and 160+ B2B2C B2B Insurers Pharma +1 +5 DRIO | Nasdaq listed | 23
Slide 24: High-Conviction Growth Levers Provide Significant Upside Opportunity
High-Conviction Growth Levers Provide Significant Upside Opportunity Management has identified clear pathways to accelerate growth across existing channels, expand product reach, and improve unit economics Growth Avenues Employers | Health Plans | Channel Partners | ▪ Continue to leverage broker/con
Slide 25: DarioHealth Commercial Evolution
DarioHealth Commercial Evolution From direct sales to channel-enabled partner leverage LEGACY SALES FUNNEL: TODAY: CHANNEL-ENABLED PARTNER NETWORK (DIRECT) DARIO PARTNERS CLIENTS MEMBERS Digital Health Platforms High CAC Expensive direct-to-employer model Third Party Admin. Employers Members Long sa
Slide 26: Dario Uses a Flexible Pricing Model Tailored to Each Commercial Channel
Dario Uses a Flexible Pricing Model Tailored to Each Commercial Channel B2B2C B2C Membership-driven Membership-driven monthly recurring revenue monthly recurring revenue Stakeholders Health Plans / Self-Insured Members per channel: PBMs Employers (Users on Dario platform) Managed Medicare & Direct t
Slide 27: Key Financial Metrics
Key Financial Metrics DRIO | Nasdaq listed | 27
Slide 28: Financial Snapshot | Q1/2026
Financial Snapshot | Q1/2026 $5.6M 57% and 80% $22.4M Second consecutive quarter of sequential growth 57% GAAP gross margin 2025 full year revenues with new ARR B2B2C business model 80% Non-GAAP gross margin B2B2C business* +7% organic QoQ vs. Q4 2025 9 consecutive quarters Transitioning to ARR mode
Slide 29: Capital Structure
Capital Structure Balance sheet & capitalization snapshot Shares Outstanding Market Cap (as of July 23, 2026) (as of July 23, 2026 based on share price of $7.47) Common Stock 9,793 K ~$73.2M Pre-Funded Warrants 3,395K As of March 31, 2026: • Cash balance and short-term deposits of $20 million • Long
Slide 30: In Summary
In Summary DRIO | Nasdaq listed | 30
Slide 31: The Time Is Now: Unprecedented Moment for Growth
The Time Is Now: Unprecedented Moment for Growth The groundwork is complete. Internal readiness & external conditions are aligned for accelerated growth Transition to Clinical Multi-Condition Expanding Chronic Care Platform Leadership Market Access Management 6+ $127M 50 chronic conditions on one Pi
Slide 32: Experienced Executive Management Team
Experienced Executive Management Team Erez Raphael Steven Nelson Chen Franco Yehuda Lara Dodo CEO, Board Member President and Chief Chief Financial Officer Chief Operating Officer Commercial Officer Omar Manejwala, M.D. Mona Dean Christopher Strafaci Rob Halpern Chief Medical Officer Chief Complianc
Slide 33: Members and Clients Love Dario
Members and Clients Love Dario Alex Health plan administrator Dylan Cardiometabolic Our customers are saving over $5,000 per For the first time, I feel Michelle individual, and they’re like I’m in control of my VP of Benefits seeing better outcomes condition instead of just as well. We saved money —